Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Equity ETF median (66 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 27 Dec 2024 – 20 Aug 2026, limited by Mirae Asset Nifty India New Age Consumption ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset Nifty India New Age Consumption ETF | Nifty 500 |
|---|---|---|
| 27 Dec 2024 | ₹100.00 | ₹100.00 |
| 15 Feb 2025 | ₹88.26 | ₹91.93 |
| 06 Apr 2025 | ₹87.63 | ₹92.69 |
| 26 May 2025 | ₹96.37 | ₹102.06 |
| 15 Jul 2025 | ₹99.63 | ₹104.47 |
| 03 Sep 2025 | ₹103.38 | ₹101.87 |
| 24 Oct 2025 | ₹104.43 | ₹105.53 |
| 13 Dec 2025 | ₹100.84 | ₹105.71 |
| 01 Feb 2026 | ₹92.17 | ₹102.83 |
| 23 Mar 2026 | ₹83.02 | ₹92.07 |
| 12 May 2026 | ₹90.75 | ₹99.35 |
| 01 Jul 2026 | ₹98.36 | ₹102.97 |
| 20 Aug 2026 | ₹104.59 | ₹104.76 |
| Metric | Mirae Asset NAV ₹12.32 Very High risk ★★☆☆☆ 1Y | Category median Equity ETF · 66 funds |
|---|---|---|
| +1.05% | +3.95% | |
| — | +11.55% | |
| — | +10.41% | |
| — | +11.81% | |
| +2.76% | +8.19% | |
| +10.04% | — | |
| — | +13.71% | |
| — | +14.22% | |
| — | +12.98% | |
| Risk | ||
| 18.86% | 17.16% | |
| -0.29 | 0.22 | |
| -0.40 | 0.32 | |
| -21.87% | -20.98% | |
| Nifty 500 | — | |
| — | +0.65% | |
| — | 1.00 | |
| — | 101.0% | |
| — | 97.0% | |
| 0.45% | 0.37% | |
| ₹50.91Cr | ₹91.02Cr | |
| 0.05% | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| — | — | |
| Ekta Gala · 1.7y | — | |
| 27 Dec 2024 | — | |
| — | — | |
| — | — | |
| 0.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.